1. Home
  2. SWX vs HUMAW Comparison

SWX vs HUMAW Comparison

Compare SWX & HUMAW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southwest Gas Holdings Inc. (DE)

SWX

Southwest Gas Holdings Inc. (DE)

HOLD

Current Price

$79.94

Market Cap

5.6B

Sector

Utilities

ML Signal

HOLD

Logo Humacyte Inc. Warrant

HUMAW

Humacyte Inc. Warrant

N/A

Current Price

$0.15

Market Cap

0.0

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
SWX
HUMAW
Founded
1931
2004
Country
United States
United States
Employees
N/A
220
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.6B
N/A
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
SWX
HUMAW
Price
$79.94
$0.15
Analyst Decision
Strong Buy
Analyst Count
4
0
Target Price
$84.50
N/A
AVG Volume (30 Days)
330.2K
14.2K
Earning Date
11-05-2025
03-21-2025
Dividend Yield
3.14%
N/A
EPS Growth
157.10
N/A
EPS
6.42
N/A
Revenue
$4,649,933,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$23.98
N/A
Revenue Growth
41.35
N/A
52 Week Low
$64.69
$1.18
52 Week High
$83.11
$1.34

Technical Indicators

Market Signals
Indicator
SWX
HUMAW
Relative Strength Index (RSI) 47.97 44.83
Support Level $78.55 $0.10
Resistance Level $83.00 $0.14
Average True Range (ATR) 1.43 0.03
MACD -0.25 0.00
Stochastic Oscillator 31.46 82.14

Price Performance

Historical Comparison
SWX
HUMAW

About SWX Southwest Gas Holdings Inc. (DE)

Southwest Gas Holdings Inc is a utility company engaged in the purchasing, distributing, and transporting of natural gas in the American Southwest. The company segments its activities into natural gas distribution and Utility Infrastructure Services units. The first of these encompasses the company's core natural gas business as distributors in the states of Arizona and Nevada. The natural gas distribution division is responsible for roughly half of Southwest Gas' total revenue through the sale of natural gas to mainly residential and small commercial customers. The Utility Infrastructure Services segment generates the other half of the company's total revenue from the underground piping contractor services that its subsidiary, Centuri Construction Group, provides.

About HUMAW Humacyte Inc. Warrant

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: